New device could save glaucoma patients' eyesight

December 6, 2016
Credit: Florida International University

People with high-risk glaucoma will be able to monitor their disease, anywhere, anytime, thanks to a new device developed by an FIU professor.

S.S. Iyengar (Ram Iyengar), director and Ryder professor of the School of Computing and Information Sciences within the College of Engineering and Computing, was just awarded a patent, along with co-inventors, for a tool that provides for glaucoma. The unnamed device works by directly monitoring intraocular pressure.

Glaucoma is an eye disease in which increased intraocular pressure causes damage to the optic nerve and leads to blindness if left untreated. Diabetics and people above age 50 who suffer from hypertension are at high-risk for developing the disease. According to Iyengar's research, it's estimated that by 2020, 11 million individuals will be blind as a result of glaucoma. Currently, more than 2.2 million Americans have the disease, but only half of them know it. Glaucoma accounts for nine to 12 percent of all cases of blindness in the United States.

For Americans, managing the disease consists of regular monitoring with an ophthalmologist, but for those living in other parts of the world, seeking treatment can be a challenge. If a patient lives in a remote village, for example, it may take hours to reach a doctor, if one is even available, and transportation may not be accessible either.

Credit: Florida International University

"In rural communities where there are no doctors, people are going blind," explained Jerry Miller, adjunct faculty and Discovery Lab research coordinator. "If there is no alternative to traveling for a day to get help, most people won't do it."

Iyengar hopes to change that with his device, which is inexpensive and easy to manufacture. "I wanted something low-cost so everyone can afford it," he said. "It's a great device for developing countries. It can cost patients as little as $15-20 once mass produced."

The device, which is the size of a small electronic chip, is surgically implanted in the eye between the iris and the cornea. Patients can keep track of their intraocular pressure, as often as once a week or more if necessary, by simply looking in the mirror. If the device changes color, there is a change in eye pressure, and the person should seek treatment right away to avoid retinal damage.

The device needs no batteries or power supply. Current devices, said Iyengar, require electric power and can be cost-prohibitive. Another competitive advantage is this device eliminates the need to see an ophthalmologist just to take a reading. Patients can monitor their own at home and seek help only when it registers as high.

Currently, Iyengar is evaluating clinical partners to conduct clinical studies. Eventually, plans are to offer the device as contact lenses.

Explore further: ECP, second drainage device effective in refractory glaucoma

Related Stories

ECP, second drainage device effective in refractory glaucoma

September 1, 2016
(HealthDay)—For patients with refractory glaucoma with failed initial tube shunt, both endoscopic cyclophotocoagulation (ECP) and implantation of a second glaucoma drainage device (GDD-2) are effective as second surgeries, ...

Membrane-tube shunt device can reduce intraocular pressure

May 12, 2016
(HealthDay)—Glaucoma surgery using a novel membrane-tube (MT) type glaucoma shunt device (MicroMT) can safely reduce intraocular pressure (IOP), according to a study published online May 3 in Clinical & Experimental Ophthalmology.

New eye pressure test could prevent vision loss in older adults

November 10, 2016
By age 75, approximately half of all Americans will develop cloudy vision caused by cataracts, according to the National Eye Institute. The most common complication from cataract surgery is high eye pressure, which can cause ...

Venlafaxine-induced rise in intraocular pressure described

May 9, 2016
(HealthDay)—In a case report published online April 30 in Clinical & Experimental Ophthalmology, venlafaxine-induced increase in intraocular pressure (IOP) is described in a patient with open angle glaucoma.

Timed-release glaucoma drug insert shows promise as alternative to daily drops

May 5, 2016
A new device that slowly releases eye medication may one day be a promising option for the many glaucoma patients who struggle with administering their own daily prescription eye drops. New research shows a medicated silicone ...

Recommended for you

World's blind population to soar: study

August 3, 2017
The world's blind will increase threefold from about 36 million today to 115 million in 2050 as populations expand and individuals grow ever older, researchers said Thursday.

Simulations signal early success for fractal-based retinal implants

July 27, 2017
Computer simulations of electrical charges sent to retinal implants based on fractal geometry have University of Oregon researchers moving forward with their eyes focused on biological testing.

Scientists regenerate retinal cells in mice

July 26, 2017
Scientists have successfully regenerated cells in the retina of adult mice at the University of Washington School of Medicine in Seattle.

Genome editing with CRISPR-Cas9 prevents angiogenesis of the retina

July 24, 2017
A research team from the Schepens Eye Research Institute of Massachusetts Eye and Ear has successfully prevented mice from developing angiogenesis of the retina—the sensory tissue at the back of the eye—using gene-editing ...

Too little vitamin D may hinder recovery of injured corneas

July 24, 2017
Injury or disease in combination with too little vitamin D can be bad for the window to your eyes.

Combination of type 2 diabetes and sleep apnoea indicates eyesight loss within four years

July 4, 2017
Research led by the University of Birmingham has discovered that patients who suffer from both Type 2 diabetes and obstructive sleep apnoea are at greater risk of developing a condition that leads to blindness within an average ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.